Tripterygium wilfordii Hook F extract is doubled compared to sulfasalazine” />

Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Internal Medicine | Rheumatology | Journal

Back to Journal Articles

Herbal Remedy May Be Effective in Rheumatoid Arthritis

Last Updated: August 18, 2009.

 

Response rate for Tripterygium wilfordii Hook F extract is doubled compared to sulfasalazine

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
In patients with active rheumatoid arthritis, treatment with peeled roots of the Chinese herbal remedy Tripterygium wilfordii Hook F may be effective and safe, according to a study published in the Aug. 18 issue of the Annals of Internal Medicine.

TUESDAY, Aug. 18 (HealthDay News) -- In patients with active rheumatoid arthritis, treatment with peeled roots of the Chinese herbal remedy Tripterygium wilfordii Hook F (TwHF) may be effective and safe, according to a study published in the Aug. 18 issue of the Annals of Internal Medicine.

Raphaela Goldbach-Mansky, M.D., of the National Institute of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, Md., and colleagues randomly assigned 121 patients to receive either daily TwHF extract or sulfasalazine. Participants were allowed to use stable doses of oral prednisone and nonsteroidal anti-inflammatory drugs as needed.

After 24 weeks, the researchers found that TwHF was associated with a significantly higher rate of achievement of 20 percent improvement than sulfasalazine (65 versus 32.8 percent) in the 62 patients who completed the study. They also found that there were no significant group differences in rates of adverse events.

"The rapid improvement in function and pain and the profound effect on inflammation may make this extract an attractive and affordable alternative to currently available agents," the authors conclude. "The long-term effects and toxicities and the potential combination of TwHF with other antirheumatic therapies need to be addressed in further studies."

One author reported two patents related to the use of TwHF. Authors also reported financial relationships with the pharmaceutical industry.

Abstract
Full Text

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Elective Induction of Labor Linked to Fewer Complications Next: Poor Guideline Adherence Found for Mitral Regurgitation

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.